Daneng Li

31PUBLICATIONS
112CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapyPacific Peoples cultural determinants of healthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 28, 2026
Multi-center Phase 1 study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388).

|Jun 30, 2026
A Randomized Phase II Study of Combination Atezolizumab and Varlilumab (CDX-1127) with or without Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer.

|Oct 30, 2025
LIF/LIFR Signaling in Gastric Cancer: A Double-Edged Sword in Tumor Progression and Therapeutic Resistance.

Daniel Park, Kyung-Il Kim, Yate-Ching Yuan

|Oct 18, 2024
Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial.

Teresa Macarulla, Zhenggang Ren, Hong Jae Chon

|Sep 14, 2024
Liver Resection for Gastroenteropancreatic Neuroendocrine Tumors with Extrahepatic Disease.

Kelly M Mahuron, Kristen E Limbach, Matthew C Hernandez

|Sep 12, 2024
Safety of pressurized intraperitoneal aerosolized chemotherapy in biliary cancer patients with peritoneal metastases.

Daneng Li, Christiana Crook, Vincent Chung

Pageof 6

Frequent Collaborators

8 joint publications

Christiana Joy Crook

4 joint publications

William Dale

3 joint publications

Mina S Sedrak

2 joint publications

Vincent Chung